Nuvalent (NUVL) EPS (Diluted) (2020 - 2026)
Nuvalent (NUVL) EPS (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.33 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.15 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.19 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Nuvalent | 9.10 Bn | 9.10 Bn | - | -1.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.39 |
| Dec 31, 2025 | -0.40 |
| Sep 30, 2025 | -1.70 |
| Jun 30, 2025 | -1.39 |
| Mar 31, 2025 | -1.18 |
| Dec 31, 2024 | -1.13 |
| Sep 30, 2024 | -1.28 |
| Jun 30, 2024 | -0.88 |
| Mar 31, 2024 | -0.69 |
| Dec 31, 2023 | -0.66 |
| Sep 30, 2023 | -0.59 |
| Jun 30, 2023 | -0.51 |
| Mar 31, 2023 | -0.44 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -0.43 |
| Jun 30, 2022 | -0.41 |
| Mar 31, 2022 | -0.38 |
| Dec 31, 2021 | -1.87 |
| Sep 30, 2021 | -0.39 |
| Jun 30, 2021 | -3.17 |